Современные методы лечения цервикальной дистонии: роль физиотерапии

Цервикальная дистония – хроническое неврологическое заболевание, характеризующееся непроизвольными сокращениями мышц шеи, приводящими к патологическому положению головы, боли, тремору и значительному снижению качества жизни. Применение ботулинического токсина типа А (БТА) остается золотым стандартом лечения, однако ее ограниченная длительность действия (2–6 месяцев) является ключевой проблемой. В обзоре представлен анализ современных методов лечения ЦД: БТА, медикаментозная терапия, глубокая стимуляция мозга (ГСМ), хирургические методы, лечебная физкультура (ЛФК), транскраниальная электростимуляция (ТЭС). Особое внимание уделено новому перспективному направлению неинвазивной нейромодуляции – транскраниальной магнитной стимуляции (ТМС), обладающему значительным потенциалом для увеличения длительности эффекта БТА за счет воздействия на нейропластичность.

1. Tyślerowicz M., Kiedrzyńska W., Adamkiewicz B., Jost W.H., Sławek J. Cervical dystonia – improving the effectiveness of botulinum toxin therapy. Neurol Neurochir Pol. 2020; 54 (3): 232–242. DOI: 10.5603/PJNNS.a2020.0021

2. Rosales R. L., Cuffe L., Regnault B., Trosch R. M. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother. 2021; 21 (10): 1125–1134. DOI: 10.1080/14737175.2021.1984230

3. Albanese A. и др. Isolated Cervical Dystonia: Diagnosis and Classification. Movement Disorders 2023; 38 (8): 1367–1378. DOI: 10.1002/mds.29387

4. O’Connor S., Hevey D., Burke T., Rafee S., Pender N., O’Keeffe F. A Systematic Review of Cognition in Cervical Dystonia. Neuropsychol Rev. 2024; 34 (1): 134–154. DOI: 10.1007/s11065-022-09558-z

5. Defazio G., Jankovic J., Giel J. L., Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (NY). 2013; 3: tre-03-193-4374-2. DOI: 10.7916/D80C4TGJ

6. Орлова О.Р. и др. Клинические рекомендации: Дистония 2024.

7. Орлова О.Р., Яхно Н.Н. Применение ботокса (токсина ботулизма типа А) в клинической практике. Каталог, 2000. С. 208.

8. Conte A., Defazio G., Hallett M., Fabbrini G., Berardelli A. The role of sensory information in the pathophysiology of focal dystonias. Nat Rev Neurol. 2019; 15 (4): 224–233. DOI: 10.1038/s41582-019-0137-9

9. Jinnah H.A., Hess E.J. Evolving concepts in the pathogenesis of dystonia. Parkinsonism Relat Disord. 2018; 46: S62–S65. DOI: 10.1016/j.parkreldis.2017.08.001

10. Leodori G. и др. Muscle theta activity in the pathophysiology of cervical dystonia. Neurobiol Dis. 2025; 212: 106969. DOI: 10.1016/j.nbd.2025.106969

11. Caverzasio S., Amato N., Chiaro G., Staedler C., Kaelin-Lang A., Galati S. Impairment of sleep homeostasis in cervical dystonia patients. Sci Rep. 2022; 12 (1): 6866. DOI: 10.1038/s41598-022-10802-y

12. Dressler D., Kopp B., Pan L., Saberi F.A. The natural course of idiopathic cervical dystonia. J. Neural Transm. 2024; 131 (3): 245–252. DOI: 10.1007/s00702-023-02736-0

13. Rosales R. L., Cuffe L., Regnault B., Trosch R. M. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother 2021; 21 (10): 1125–1134. DOI: 10.1080/14737175.2021.1984230

14. Maione R., Formica C., Quartarone A., Lo Buono V. The Impact of Non-Motor Symptoms on Quality of Life in Cervical Dystonia. J. Clin Med. 2023; 12 (14): 4663. DOI: 10.3390/jcm12144663

15. Loens S. и др. Validation of clinical ratings of cervical dystonia using computer-generated avatars. Parkinsonism Relat Disord. 2025; 107975. DOI: 10.1016/j.parkreldis.2025.107975

16. Castagna A., Albanese A. Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance. Neurol Clin Pract. 2019; 9 (1): 64–73. DOI: 10.1212/CPJ.0000000000000568

17. Ndukwe I., O’Riordan S., Walsh C.B., Hutchinson M. Trust the Patient Not the Doctor: The Determinants of Quality of Life in Cervical Dystonia. Front Neurol. 2020; Т. 11: 991. DOI: 10.3389/fneur.2020.00991

18. Klingelhoefer L. и др. Validation of a self-completed Dystonia Non-Motor Symptoms Questionnaire. Ann Clin Transl Neurol. 2019; 6 (10): 2054–2065. DOI: 10.1002/acn3.50900

19. Erro R., Picillo M., Pellecchia M.T., Barone P. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review. Toxins (Basel). 2023; 15 (6): 391. DOI: 10.3390/toxins15060391

20. Shipkov H. et al. Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review. Life 2025; 15 (6): 920. DOI: 10.3390/life15060920

21. Yahalom G., Fay-Karmon T., Livneh V., Israeli-Korn S., Ephraty L., Hassin-Baer S. Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study. Neurotox Res. 2021; 39 (4): 1352–1359. DOI: 10.1007/s12640-021-00378-2

22. Walter U., Albrecht P., Carr W., Hefter H. Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications. Eur J. Neurol. 2025; 32 (8): e70289. DOI: 10.1111/ene.70289

23. Albanese A. и др. Definition and Classification of Dystonia. Movement Disorders 2025; 40 (7): 1248–1259. DOI: 10.1002/mds.30220

24. Ortiz R., Scheperjans F., Mertsalmi T., Pekkonen E. The prevalence of adult-onset isolated dystonia in Finland 2007–2016. PLoS One 2018; 13 (11): e0207729. DOI: 10.1371/journal.pone.0207729

25. Dashtipour K., Mari Z., Jankovic J., Adler C.H., Schwartz M., Brin M.F. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study. J. Neurol Sci. 2019; 405: 116413. DOI: 10.1016/j.jns.2019.07.031

26. Chen S. Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments. Toxins (Basel). 2012; 4 (10): 913–939. DOI: 10.3390/toxins4100913

27. Carr W.W., Jain N., Sublett J.W. Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications. Adv Ther. 2021; 38 (10): 5046–5064. DOI: 10.1007/s12325-021-01882-9

28. Volkmann J. и др. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014; 13 (9): 875–884. DOI: 10.1016/S1474-4422(14)70143-7

29. Trosch R.M. и др. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry. J. Neurol Sci. 2017; 376: 84–90. DOI: 10.1016/j.jns.2017.02.042

30. Jinnah H.A. Medical and Surgical Treatments for Dystonia. Neurol Clin. 2020; 38 (2): 325–348. DOI: 10.1016/j.ncl.2020.01.003

31. Andre L., Gallini A., Montastruc F., Montastruc J.-L., Piau A., Lapeyre-Mestre M., Gardette V. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review. Eur. J. Clin Pharmacol. 2019; 75 (12): 1631–1644. DOI: 10.1007/s00228-019-02744-8

32. Tsuboi T., Cauraugh J.H., Wong J.K., Okun M.S., Ramirez-Zamora A. Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis. J. Neurol Neurosurg Psychiatry. 2020; 91 (9): 938–944. DOI: 10.1136/jnnp-2019-322575

33. Tsuboi T., Wong J.K., Almeida L., Hess C.W., Wagle Shukla A., Foote K.D., Okun M.S., Ramirez-Zamora A. A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystonia. J. Neurol. 2020; 267 (5): 1278–1290. DOI: 10.1007/s00415-020-09703-9

34. Khanom A.A., Franceschini P.R., Lane S., Osman-Farah J., Macerollo A. Bilateral globus pallidus internus (GPi) deep brain stimulation for cervical dystonia: Effects on motor and non-motor symptoms within 5 years follow. J. Neurol Sci. 2023; 452: 120752. DOI: 10.1016/j.jns.2023.120752

35. Albanese A. и др. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur. J. Neurol. 2006; 13 (5): 433–444. DOI: 10.1111/j.1468-1331.2006.01537.x

36. Wilson T.J., Spinner R.J. Selective Cervical Denervation for Cervical Dystonia: Modification of the Bertrand Procedure. Operative Neurosurgery. 2018; 14 (5): 546–555. DOI: 10.1093/ons/opx147

37. Ravindran K., Ganesh Kumar N., Englot D.J., Wilson T.J., Zuckerman S.L. Deep Brain Stimulation Versus Peripheral Denervation for Cervical Dystonia: A Systematic Review and Meta-Analysis. World Neurosurg. 2019; 122: e940–e946. DOI:10.1016/j.wneu.2018.10.178

38. Tassorelli C., Mancini F., Balloni L., Pacchetti C., Sandrini G., Nappi G., Martignoni E. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Movement Disorders 2006; 21 (12): 2240–2243. DOI: 10.1002/mds.21145

39. Prudente C.N., Zetterberg L., Bring A., Bradnam L., Kimberley T. J. Systematic Review of Rehabilitation in Focal Dystonias: Classification and Recommendations. Mov Disord Clin Pract. 2018; 5 (3): 237–245. DOI: 10.1002/mdc3.12574

40. Hashimoto Y., Ota T., Mukaino M., Liu M., Ushiba J. Functional recovery from chronic writer’s cramp by brain-computer interface rehabilitation: a case report. BMC Neurosci. 2014; 15: 103. DOI: 10.1186/1471-2202-15-103

41. De Pauw J., Van der Velden K., Meirte J., Van Daele U., Truijen S., Cras P., Mercelis R., De Hertogh W. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J. Neurol. 2014; 261 (10): 1857–1865. DOI: 10.1007/s00415-013-7220-8

42. Loudovici-Krug D., Derlien S., Best N., Günther A. Physiotherapy for Cervical Dystonia: A Systematic Review of Randomised Controlled Trials. Toxins (Basel). 2022; 14 (11): 784. DOI: 10.3390/toxins14110784

43. Zaghi S., de Freitas Rezende L., de Oliveira L.M., El-Nazer R., Menning S., Tadini L., Fregni F. Inhibition of motor cortex excitability with 15Hz transcranial alternating current stimulation (tACS). Neurosci Lett. 2010; 479 (3): 211–214. DOI: 10.1016/j.neulet.2010.05.060

44. Ganguly J., Murgai A., Sharma S., Aur D., Jog M. Non-invasive Transcranial Electrical Stimulation in Movement Disorders. Front Neurosci. 2020; 14: 522. DOI: 10.3389/fnins.2020.00522

45. Bleton J.-P., Cossé C., Caloc’h T., Suarez Moreno A., Diverres E., Derkinderen P., Nizard J., Lefaucheur J.-P., Nguyen J.-P. Combination of anodal tDCS of the cerebellum with a goal-oriented motor training to treat cervical dystonia: a pilot case series. Front Neurol. 2024; 15: 1381390. DOI: 10.3389/fneur.2024.1381390

46. Pirio Richardson S., Tinaz S., Chen R. Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial. PLoS One. 2015; 10 (4): e0124937. DOI: 10.1371/journal.pone.0124937

47. Sigrist C., Vöckel J., MacMaster F.P., Farzan F., Croarkin P.E., Galletly C., Kaess M., Bender S., Koenig J. Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. Eur. Child Adolesc Psychiatry. 2022; 31 (10): 1501–1525. DOI: 10.1007/s00787-022-02021-7

48. Hallett M. Transcranial Magnetic Stimulation: A Primer. Neuron. 2007; 55 (2): 187–199. DOI: 10.1016/j.neuron.2007.06.026

49. Lefaucheur J.-P. и др. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clinical Neurophysiology. 2020; 131 (2): 474–528. DOI: 10.1016/j.clinph.2019.11.002

50. Pirio Richardson S. Enhanced dorsal premotor–motor inhibition in cervical dystonia. Clinical Neurophysiology. 2015; 126 (7): 1387–1391. DOI: 10.1016/j.clinph.2014.10.140

51. Bologna M., Paparella G., Fabbrini A., Leodori G., Rocchi L., Hallett M., Berardelli A. Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia. Clinical Neurophysiology. 2016; 127 (11): 3472–3479. DOI: 10.1016/j.clinph.2016.09.008

52. Zittel S., Helmich R.C., Demiralay C., Münchau A., Bäumer T. Normalization of sensorimotor integration by repetitive transcranial magnetic stimulation in cervical dystonia. J. Neurol. 2015; 262 (8): 1883–1889. DOI: 10.1007/s00415-015-7789-1

53. Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology. 2009; 120 (12): 2008–2039. DOI: 10.1016/j.clinph.2009.08.016

54. Schrader L.M., Stern J.M., Fields T.A., Nuwer M.R., Wilson C.L. A lack of effect from transcranial magnetic stimulation (TMS) on the vagus nerve stimulator (VNS). Clinical Neurophysiology. 2005; 116 (10): 2501–2504. DOI: 10.1016/j.clinph.2005.06.025

55. Loo C.K., McFarquhar T.F., Mitchell P.B. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. International Journal of Neuropsychopharmacology. 2008; 11 (1): 131–147. DOI: 10.1017/S1461145707007717